PROM1 and breast carcinoma: In breast carcinomas, the expression of CD133 and its relation with histopathological parameters has yielded conflicting results which may be attributed to different research methodologies and differences between study populations (Mukhopadhyay et al., 2013; Zhan et al., 2017; Kim et al., 2015; Margaret et al., 2013).